- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02946255
Testing the Effectiveness of The Welcome Basket Intervention
Testing the Effectiveness of a Brief, Peer Support Intervention to Facilitate Transition Form Psychiatric Hospitalization
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Discharge from hospital has been highlighted as a critical time in the care of individuals with mental illness. The peak period of risk for readmission for individuals with severe mental illness is in the first month and the highest risk for post-discharge suicide is within the first 2 weeks with discontinuity of contact with providers highlighted as a key risk factor. One half of individuals with schizophrenia miss their first-scheduled outpatient appointment following discharge and this time is a key period of risk for medication non-compliance. Common problems that occur at the time of discharge from psychiatric care settings include poor communication between inpatient and outpatient providers and inadequate involvement and support of families. The research literature on effective practices linked with discharge is strikingly sparse given the evidence that this is a period of heightened risk.
The investigators hypothesize that the Welcome Basket intervention will improve the discharge-related outcomes of individuals with schizophrenia or bipolar disorder with psychotic features compared to treatment as usual. Investigators will also explore the outcomes of an abbreviated, 2-visit version of the intervention. This study will employ a randomized, controlled trial design. Inpatient clients with a diagnosis of schizophrenia spectrum mental illness or bipolar disorder with psychotic features will be randomized with a 2:2:1 ratio to: treatment as usual, the full welcome basket intervention, and the abbreviated intervention. Measures will include re-hospitalization, symptomatology, quality of life, and community functioning. Assessments at baseline, 4 weeks post-discharge, and 6 months post-discharge will facilitate studies of relative effectiveness and sustainment of gains. This design will facilitate an examination of both overall outcomes as well as some preliminary dismantling of mechanisms of action.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Ontario
-
Toronto, Ontario, Canada, M5T 1R8
- Centre for Addiction and Mental Health
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Participants will be adults, 18 years of age or older, with a chart diagnosis of a schizophrenia spectrum mental illness or bipolar disorder with psychotic features confirmed by Module B (psychotic symptoms) of the Structured Clinical Interview for DSM-5 (SCID-5) (First, William, Karg, & Spitzer, 2015). All participants will be on CAMH inpatient units at the time of recruitment and will have been in continuous inpatient care for close to or more than 2 weeks. This timeframe is guided by the rationale and experience indicating that an overly brief period of hospitalization circumscribes the relevance of the intervention.
- Participants will be returning to places of residence in the Greater Toronto Area (catchment of CAMH) or can travel to the GTA if they will reside outside the catchment area.
- Participants must have been referred to outpatient case management.
- Proposed housing arrangements must be stable and conducive to the intervention. If homelessness or emergency shelter residence appears likely, or boarding home policy precludes any external staff from entering the premises, such individuals will be excluded.
- Proficiency in English.
Exclusion criteria:
1. Do not meet the above criteria.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Welcome Basket Brief (WBbr)
The brief version of the Welcome Basket (WBbr) was developed based upon the observation in feasibility testing that for some participants much of the benefit of this approach appeared to be centred upon the visits immediately prior and subsequent to discharge.
In the WBbr the same core components will be present, albeit in an abbreviated form with one 30-60 minute visit in the week prior to discharge and a single, 3-hour visit in the week subsequent to discharge in which the welcome basket would be delivered, core CAT strategies discussed and implemented, and some basic orientation to community resources undertaken.
This brief version of the intervention has not to date been studied.
|
The brief version of the Welcome Basket (WBbr) was developed based upon the observation in feasibility testing that for some participants much of the benefit of this approach appeared to be centred upon the visits immediately prior and subsequent to discharge.
In the WBbr the same core components will be present, albeit in an abbreviated form with one 30-60 minute visit in the week prior to discharge and a single, 3-hour visit in the week subsequent to discharge in which the welcome basket would be delivered, core CAT strategies discussed and implemented, and some basic orientation to community resources undertaken.
This brief version of the intervention has not to date been studied.
|
Experimental: Welcome Basket (WB)
Peer Support Workers (PSWs) hold 1-2 meetings with clients (30-60 minutes) in the 2-week period before they are discharged from hospital.
They describe the program and undertake an assessment.
From this assessment the two core components of the intervention are initiated.
First, a "welcome basket" is created for the client.
The PSW also forms a plan with the client about tours of their neighbourhood to familiarize them with the local resources and support them in building confidence in accessing their local communities.
These activities will take place through weekly visits (2 hours/visit) in the 4 weeks immediately following discharge.
WB will be provided in combination with core Cognitive Adaptation Training (CAT) compensatory interventions.
|
Peer Support Workers (PSWs) hold 1-2 meetings with clients (30-60 minutes) in the 2-week period before they are discharged from hospital.
They describe the program and undertake an assessment.
From this assessment the two core components of the intervention are initiated.
First, a "welcome basket" is created for the client.
The PSW also forms a plan with the client about tours of their neighbourhood to familiarize them with the local resources and support them in building confidence in accessing their local communities.
These activities will take place through weekly visits (2 hours/visit) in the 4 weeks immediately following discharge.
WB will be provided in combination with core Cognitive Adaptation Training (CAT) compensatory interventions.
|
Active Comparator: Treatment As Usual
Treatment as usual (TAU) involves the typical discharge procedures for clients from Unit 2, Forensic and EPU wards at CAMH.
It includes referral to outpatient psychiatric services and relevant community supports with the transition facilitated by inpatient social work staff.
|
Treatment as usual (TAU) involves the typical discharge procedures for clients from Unit 2, Forensic and EPU wards at CAMH.
It includes referral to outpatient psychiatric services and relevant community supports with the transition facilitated by inpatient social work staff.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Multnomah Community Ability Scale - Participant Interview Based
Time Frame: Baseline
|
Community Functioning and change in adaptive functioning will be assessed with the Multnomah Community Ability Scale (MCAS), a 17-item scale assessing domains of functionality including health, adjustment to living, social competence, and behavioral problems (completed at all time points).
This measure best reflects the primary aim of this intervention: to support a greater degree of illness self-management, independence, and level of community activity.
The MCAS will be scored based upon interviews with participants and by the primary clinician (inpatient for baseline and case managers for post and follow up measures).
The total score is reported here and is the sum of the 4 subscale totals (Health, Adaptation, Social Skills, Behaviour).
The min total score is 17 and the max is 85 with higher values representing better outcomes.
|
Baseline
|
Multnomah Community Ability Scale - Participant Interview Based
Time Frame: 4 Week Follow-Up
|
Community Functioning and change in adaptive functioning will be assessed with the Multnomah Community Ability Scale (MCAS), a 17-item scale assessing domains of functionality including health, adjustment to living, social competence, and behavioral problems (completed at all time points).
This measure best reflects the primary aim of this intervention: to support a greater degree of illness self-management, independence, and level of community activity.
The MCAS will be scored based upon interviews with participants and by the primary clinician (inpatient for baseline and case managers for post and follow up measures).
The total score is reported here and is the sum of the 4 subscale totals (Health, Adaptation, Social Skills, Behaviour).
The min total score is 17 and the max is 85 with higher values representing better outcomes.
|
4 Week Follow-Up
|
Multnomah Community Ability Scale - Participant Interview Based
Time Frame: 6 Month Follow-Up
|
Community Functioning and change in adaptive functioning will be assessed with the Multnomah Community Ability Scale (MCAS), a 17-item scale assessing domains of functionality including health, adjustment to living, social competence, and behavioral problems (completed at all time points).
This measure best reflects the primary aim of this intervention: to support a greater degree of illness self-management, independence, and level of community activity.
The MCAS will be scored based upon interviews with participants and by the primary clinician (inpatient for baseline and case managers for post and follow up measures).
The total score is reported here and is the sum of the 4 subscale totals (Health, Adaptation, Social Skills, Behaviour).
The min total score is 17 and the max is 85 with higher values representing better outcomes.
|
6 Month Follow-Up
|
Multnomah Community Ability Scale - Clinician Based
Time Frame: Baseline
|
Community Functioning and change in adaptive functioning will be assessed with the Multnomah Community Ability Scale (MCAS), a 17-item scale assessing domains of functionality including health, adjustment to living, social competence, and behavioral problems (completed at all time points).
This measure best reflects the primary aim of this intervention: to support a greater degree of illness self-management, independence, and level of community activity.
The MCAS will be scored based upon interviews with participants and by the primary clinician (inpatient for baseline and case managers for post and follow up measures).
The total score is reported here and is the sum of the 4 subscale totals (Health, Adaptation, Social Skills, Behaviour).
The min total score is 17 and the max is 85 with higher values representing better outcomes.
|
Baseline
|
Multnomah Community Ability Scale - Clinician Based
Time Frame: 4 Week Follow-Up
|
Community Functioning and change in adaptive functioning will be assessed with the Multnomah Community Ability Scale (MCAS), a 17-item scale assessing domains of functionality including health, adjustment to living, social competence, and behavioral problems (completed at all time points).
This measure best reflects the primary aim of this intervention: to support a greater degree of illness self-management, independence, and level of community activity.
The MCAS will be scored based upon interviews with participants and by the primary clinician (inpatient for baseline and case managers for post and follow up measures).
The total score is reported here and is the sum of the 4 subscale totals (Health, Adaptation, Social Skills, Behaviour).
The min total score is 17 and the max is 85 with higher values representing better outcomes.
|
4 Week Follow-Up
|
Multnomah Community Ability Scale - Clinician Based
Time Frame: 6 Month Follow-Up
|
Community Functioning and change in adaptive functioning will be assessed with the Multnomah Community Ability Scale (MCAS), a 17-item scale assessing domains of functionality including health, adjustment to living, social competence, and behavioral problems (completed at all time points).
This measure best reflects the primary aim of this intervention: to support a greater degree of illness self-management, independence, and level of community activity.
The MCAS will be scored based upon interviews with participants and by the primary clinician (inpatient for baseline and case managers for post and follow up measures).
The total score is reported here and is the sum of the 4 subscale totals (Health, Adaptation, Social Skills, Behaviour).
The min total score is 17 and the max is 85 with higher values representing better outcomes.
|
6 Month Follow-Up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Hospitalizations and Emergency Room Visits
Time Frame: Baseline to 6 Month Follow-Up
|
The percentage of participants that were re-hospitalized or visited the emergency room during the study were captured through case manager report and verified through hospital electronic database if a CAMH hospitalization.
|
Baseline to 6 Month Follow-Up
|
The Satisfaction With Life Scale
Time Frame: 4 Week Follow-Up
|
Quality of Life will be assessed with the Satisfaction With Life scale, an 18-item scale comprised of 4 subscales assessing living situation (4 items), social relationships (6 items), work (2 items), self and present life (6 items).
Items are rated from 0 (not at all) to 1 (very little) to 2 (average or OK) to 3 (a lot) to 4 (a great deal).
Subscale scores are reported here.
The min value for all subscales is 0. The max value for the Living Situation subscale is 16.
The max value for both the Social Relationships subscale and the Self and Present Life subscale is 24.
The max value for the Work subscale is 8. Higher subscale scores indicate better outcomes (i.e., greater satisfaction with that area of life).
|
4 Week Follow-Up
|
The Satisfaction With Life Scale
Time Frame: 6 Month Follow-Up
|
Quality of Life will be assessed with the Satisfaction With Life scale, an 18-item scale comprised of 4 subscales assessing living situation (4 items), social relationships (6 items), work (2 items), self and present life (6 items).
Items are rated from 0 (not at all) to 1 (very little) to 2 (average or OK) to 3 (a lot) to 4 (a great deal).
Subscale scores are reported here.
The min value for all subscales is 0. The max value for the Living Situation subscale is 16.
The max value for both the Social Relationships subscale and the Self and Present Life subscale is 24.
The max value for the Work subscale is 8. Higher subscale scores indicate better outcomes (i.e., greater satisfaction with that area of life).
|
6 Month Follow-Up
|
Social Support Survey
Time Frame: Baseline
|
Quality of Life will also be assessed using the Social Support Survey, a 19 item scale that measures emotional/information support, tangible support, affectionate support and positive social interaction.
Overall support index (i.e., Total Score) is reported here and is calculated from averaging all items and then applying a transformation [i.e., minimum possible score subtracted from observed score (first difference) and maximum possible score (second difference) and then the first difference divided by the second difference and that quotient multiplied by 100] such that the min score is 0 and the max is 100.
Higher scores indicate better outcomes (i.e., more frequent availability of different types of support).
|
Baseline
|
Social Support Survey
Time Frame: 4 Week Follow-Up
|
Quality of Life will also be assessed using the Social Support Survey, a 19 item scale that measures emotional/information support, tangible support, affectionate support and positive social interaction.
Overall support index (i.e., Total Score) is reported here and is calculated from averaging all items and then applying a transformation [i.e., minimum possible score subtracted from observed score (first difference) and maximum possible score (second difference) and then the first difference divided by the second difference and that quotient multiplied by 100] such that the min score is 0 and the max is 100.
Higher scores indicate better outcomes (i.e., more frequent availability of different types of support).
|
4 Week Follow-Up
|
Social Support Survey
Time Frame: 6 Month Follow-Up
|
Quality of Life will also be assessed using the Social Support Survey, a 19 item scale that measures emotional/information support, tangible support, affectionate support and positive social interaction.
Overall support index (i.e., Total Score) is reported here and is calculated from averaging all items and then applying a transformation [i.e., minimum possible score subtracted from observed score (first difference) and maximum possible score (second difference) and then the first difference divided by the second difference and that quotient multiplied by 100] such that the min score is 0 and the max is 100.
Higher scores indicate better outcomes (i.e., more frequent availability of different types of support).
|
6 Month Follow-Up
|
Brief Symptom Inventory
Time Frame: Baseline
|
Changes in symptomatology will be assessed with the 53 item Brief Symptom Inventory (BSI); this widely used instrument has extensively demonstrated validity and reliability properties and assesses a wide range of symptom areas.
Participants rank how distressing symptoms are from 0 (not at all) to 4 (a great deal).
The 52 items are organized into 9 symptom dimensions: Somatization, Obsession-Compulsions, Interpersonal Sensitivity Items, Depression, Anxiety, Hostility, Phobic Anxiety, Paranoid Ideation, and Psychoticism.
Dimension scores are calculated by summing the values for the items included in that dimension and dividing by the number of items endorsed in that dimension.
The Global Severity Index (GSI) is reported here.
The GSI is calculated by summing all the dimensions plus four additional items and dividing by the total number of items responded to.
The min value is 0 and the max value is 72.
Higher scores indicate worse outcomes (i.e., more distressing symptoms).
|
Baseline
|
Brief Symptom Inventory
Time Frame: 4 Week Follow-Up
|
Changes in symptomatology will be assessed with the 53 item Brief Symptom Inventory (BSI); this widely used instrument has extensively demonstrated validity and reliability properties and assesses a wide range of symptom areas.
Participants rank how distressing symptoms are from 0 (not at all) to 4 (a great deal).
The 52 items are organized into 9 symptom dimensions: Somatization, Obsession-Compulsions, Interpersonal Sensitivity Items, Depression, Anxiety, Hostility, Phobic Anxiety, Paranoid Ideation, and Psychoticism.
Dimension scores are calculated by summing the values for the items included in that dimension and dividing by the number of items endorsed in that dimension.
The Global Severity Index (GSI) is reported here.
The GSI is calculated by summing all the dimensions plus four additional items and dividing by the total number of items responded to.
The min value is 0 and the max value is 72.
Higher scores indicate worse outcomes (i.e., more distressing symptoms).
|
4 Week Follow-Up
|
Brief Symptom Inventory
Time Frame: 6 Month Follow-Up
|
Changes in symptomatology will be assessed with the 53 item Brief Symptom Inventory (BSI); this widely used instrument has extensively demonstrated validity and reliability properties and assesses a wide range of symptom areas.
Participants rank how distressing symptoms are from 0 (not at all) to 4 (a great deal).
The 52 items are organized into 9 symptom dimensions: Somatization, Obsession-Compulsions, Interpersonal Sensitivity Items, Depression, Anxiety, Hostility, Phobic Anxiety, Paranoid Ideation, and Psychoticism.
Dimension scores are calculated by summing the values for the items included in that dimension and dividing by the number of items endorsed in that dimension.
The Global Severity Index (GSI) is reported here.
The GSI is calculated by summing all the dimensions plus four additional items and dividing by the total number of items responded to.
The min value is 0 and the max value is 72.
Higher scores indicate worse outcomes (i.e., more distressing symptoms).
|
6 Month Follow-Up
|
Global Appraisal of Individual Needs (GAIN) - Short Screener Substance Disorder Subscale
Time Frame: Baseline
|
The 5-item Global Appraisal of Individual Needs Short Screener (GAIN-SS) Substance Disorder Subscale (5-items) will be used to measure common psychological, behavioral, and personal problems related to alcohol and drug use.
Each item is rated from 4 to 0 with 4, 3 and 2 representing use or problems in the past month, 2-3 months ago and 4-12 months ago, respectively.
Items rated 1 represent problems over a year ago and items rated 0 indicate never having that problem.
The subscale score is the total number of responses that indicate substance use problems within the last year.
Substance Disorder Subscale scores for each arm are reported here.
The min value is 0 and the max value is 5. Higher scores indicate worse outcomes (i.e., more severe problems related to substance use).
|
Baseline
|
Global Appraisal of Individual Needs (GAIN) - Short Screener Substance Disorder Subscale
Time Frame: 4 Week Follow-Up
|
The 5-item Global Appraisal of Individual Needs Short Screener (GAIN-SS) Substance Disorder Subscale (5-items) will be used to measure common psychological, behavioral, and personal problems related to alcohol and drug use.
Each item is rated from 4 to 0 with 4, 3 and 2 representing use or problems in the past month, 2-3 months ago and 4-12 months ago, respectively.
Items rated 1 represent problems over a year ago and items rated 0 indicate never having that problem.
The subscale score is the total number of responses that indicate substance use problems within the last year.
Substance Disorder Subscale scores for each arm are reported here.
The min value is 0 and the max value is 5. Higher scores indicate worse outcomes (i.e., more severe problems related to substance use).
|
4 Week Follow-Up
|
Global Appraisal of Individual Needs (GAIN) - Short Screener Substance Disorder Subscale
Time Frame: 6 Month Follow-Up
|
The 5-item Global Appraisal of Individual Needs Short Screener (GAIN-SS) Substance Disorder Subscale (5-items) will be used to measure common psychological, behavioral, and personal problems related to alcohol and drug use.
Each item is rated from 4 to 0 with 4, 3 and 2 representing use or problems in the past month, 2-3 months ago and 4-12 months ago, respectively.
Items rated 1 represent problems over a year ago and items rated 0 indicate never having that problem.
The subscale score is the total number of responses that indicate substance use problems within the last year.
Substance Disorder Subscale scores for each arm are reported here.
The min value is 0 and the max value is 5. Higher scores indicate worse outcomes (i.e., more severe problems related to substance use).
|
6 Month Follow-Up
|
Personal Recovery Outcome Measure
Time Frame: Baseline
|
The brief, 10-item version of the Personal Recovery Outcome Measure was used to assess change in recovery engagement.
Total score is reported here.
Total score is calculated by summing all the responses.
Min total score value is 0 and max total score value is 40.
Higher scores indicate better outcomes (i.e., more engagement in recovery).
|
Baseline
|
Personal Recovery Outcome Measure
Time Frame: 4 Week Follow-Up
|
The brief, 10-item version of the Personal Recovery Outcome Measure was used to assess change in recovery engagement.
Total score is reported here.
Total score is calculated by summing all the responses.
Min total score value is 0 and max total score value is 40.
Higher scores indicate better outcomes (i.e., more engagement in recovery).
|
4 Week Follow-Up
|
Personal Recovery Outcome Measure
Time Frame: 6 Month Follow-Up
|
The brief, 10-item version of the Personal Recovery Outcome Measure was used to assess change in recovery engagement.
Total score is reported here.
Total score is calculated by summing all the responses.
Min total score value is 0 and max total score value is 40.
Higher scores indicate better outcomes (i.e., more engagement in recovery).
|
6 Month Follow-Up
|
Community Integration Scale
Time Frame: 4 Week Follow-Up
|
Community involvement will be assessed with the 11 item Community Integration Scale which was developed for the At Home study with a comparable population to assesses psychological and behavioural community engagement.
The first 7 items measure physical integration (community presence) and the remaining 4 items measure psychological integration (sense of belonging).
Community Involvement was assessed post intervention and at follow up and not during inpatient stay since it would not be valid due to contextual confounds with items.
Total scores (i.e, the average of the responses) are reported here.
The min total score value is -1 and the max is 2.5.
Higher scores indicate better outcomes (i.e., greater community engagement)
|
4 Week Follow-Up
|
Community Integration Scale
Time Frame: 6 Month Follow-Up
|
Community involvement will be assessed with the 11 item Community Integration Scale which was developed for the At Home study with a comparable population to assesses psychological and behavioural community engagement.
The first 7 items measure physical integration (community presence) and the remaining 4 items measure psychological integration (sense of belonging).
Community Involvement was assessed post intervention and at follow up and not during inpatient stay since it would not be valid due to contextual confounds with items.
Total scores (i.e, the average of the responses) are reported here.
The min total score value is -1 and the max is 2.5.
Higher scores indicate better outcomes (i.e., greater community engagement)
|
6 Month Follow-Up
|
Collaborators and Investigators
Investigators
- Principal Investigator: Sean A Kidd, PhD, Centre for Addiction and Mental Health
Publications and helpful links
General Publications
- Sherbourne CD, Stewart AL. The MOS social support survey. Soc Sci Med. 1991;32(6):705-14. doi: 10.1016/0277-9536(91)90150-b.
- Birchwood M, Smith J, Cochrane R, Wetton S, Copestake S. The Social Functioning Scale. The development and validation of a new scale of social adjustment for use in family intervention programmes with schizophrenic patients. Br J Psychiatry. 1990 Dec;157:853-9. doi: 10.1192/bjp.157.6.853.
- Barker S, Barron N, McFarland BH, Bigelow DA. A community ability scale for chronically mentally ill consumers: Part I. Reliability and validity. Community Ment Health J. 1994 Aug;30(4):363-83. doi: 10.1007/BF02207489.
- Lee, K., Brekke, J., Yamada, A., & Chou, C. (2010). Longitudinal invariance of the satisfaction with life scale for individuals with schizophrenia. Research on Social Work Practice, 20(2), 234-241.
- Derogatis, L.R.(1993). BSI Brief Symptom Inventory: Administration, Scoring, and Procedure Manual (4th Ed.). Minneapolis, MN: National Computer Systems.
- Barbic, S., Kidd, SA, Backman, C., MacEwan, W.. Honer, W., & McKenzie, K. (2016). The development and testing of the Personal Recovery Outcome Measure (PROM) [in preparation].
- Stergiopoulos V, Gozdzik A, Misir V, Skosireva A, Connelly J, Sarang A, Whisler A, Hwang SW, O'Campo P, McKenzie K. Effectiveness of Housing First with Intensive Case Management in an Ethnically Diverse Sample of Homeless Adults with Mental Illness: A Randomized Controlled Trial. PLoS One. 2015 Jul 15;10(7):e0130281. doi: 10.1371/journal.pone.0130281. eCollection 2015.
- First MB, William JBW, Karg RS, Spitzer RL: Structured Clinical Interview for DSM-5-Research Version (SCID-5 for DSM-5, Research Version; SCRID-5-RV). Arlington,VA, American Psychiatric-Association, 2015.
- Dennis ML, Chan YF, Funk RR. Development and validation of the GAIN Short Screener (GSS) for internalizing, externalizing and substance use disorders and crime/violence problems among adolescents and adults. Am J Addict. 2006;15 Suppl 1(Suppl 1):80-91. doi: 10.1080/10550490601006055.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 073/2016
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Psychosis
-
Icahn School of Medicine at Mount SinaiNational Institute of Mental Health (NIMH)RecruitingFirst Episode Psychosis (FEP) | Clinical High Risk for Psychosis (CHR)United States
-
University of UdineNational Research Council (CNR), Institute of Biomolecular Chemistry (ICB)...RecruitingClinical High Risk for Psychosis | Ultra High Risk for Psychosis | Attenuated Psychotic SymptomsItaly
-
University of New MexicoNational Institute of Mental Health (NIMH)CompletedPsychosis | Clinical High Risk for Psychosis | First Episode PsychosisUnited States
-
Chulalongkorn UniversityNational Research Council of Thailand; Thanyarak InstituteCompletedMethamphetamine-induced PsychosisThailand
-
Shanghai Jiao Tong University School of MedicineGuangzhou Psychiatric Hospital; Suzhou Psychiatric Hospital; Tianjin Anding Hospital and other collaboratorsRecruitingSchizophrenia; Psychosis | Clinical High Risk | First Episode PsychosisChina
-
University of California, San DiegoCenter for Medicinal Cannabis ResearchRecruitingEarly PsychosisUnited States
-
Yale UniversityCompleted
-
University of TorontoUniversity of British Columbia; Centre for Addiction and Mental Health; Queen... and other collaboratorsNot yet recruitingPsychotic Disorders | Schizophrenia | Psychosis | Schizophrenia; Psychosis
-
Northwell HealthNational Institute of Mental Health (NIMH)RecruitingFirst Episode PsychosisUnited States
-
State reference center for psychosocial careUniversity of ValenciaCompleted